Report cover image

Europe Transgenic Animal Model Market: Focus on Technology, Animal Type, Application, End User, and Country - Analysis and Forecast, 2025-2035

Publisher BIS Research
Published May 26, 2026
Length 80 Pages
SKU # BIS21159073

Description

Market Overview

The Europe transgenic animal model market is experiencing steady growth, driven by increasing demand for advanced preclinical research tools, rising investments in biotechnology, and expanding applications in drug discovery and genetic research. Transgenic animal models play a critical role in understanding disease mechanisms and developing targeted therapeutics. The global transgenic animal model market is expected to witness significant growth during the forecast period 2025-2035, with Europe emerging as a key regional contributor due to strong research infrastructure and regulatory support. Countries such as Germany, the U.K., and France are at the forefront, fostering innovation in genetic engineering and biomedical research. The Europe transgenic animal model market is projected to reach $2,234.7 million by 2035 from $906.5 million in 2025, growing at a CAGR of 9.44% during the forecast period 2025-2035.

Market Introduction

The Europe transgenic animal model market represents a vital segment of the life sciences and biotechnology industry, focusing on genetically modified animals that carry foreign genes inserted into their genome. These models are widely used in biomedical research to study gene function, disease progression, and therapeutic responses. Transgenic animal models, particularly mice and rats, have become indispensable tools in preclinical research, enabling scientists to replicate human disease conditions with high accuracy.

In Europe, the demand for transgenic animal models is being driven by increasing research activities in genomics, oncology, neurology, and rare diseases. The region’s strong academic and research ecosystem, supported by government funding and collaborations with pharmaceutical and biotechnology companies, is accelerating the adoption of advanced genetic engineering technologies such as CRISPR/Cas9 and gene editing platforms.

Moreover, the rising focus on personalized medicine and targeted therapies is further boosting the need for precise and reliable animal models. Regulatory frameworks in Europe ensure ethical use and standardization, promoting high-quality research practices. Additionally, the presence of leading research institutions and biotech firms is fostering innovation and commercialization of transgenic animal models.

As the demand for efficient drug development and disease modeling grows, the Europe transgenic animal model market is poised for significant expansion, supported by technological advancements and increasing R&D investments.

Market Segmentation:

Segmentation 1: By Technology

CRISPR/CAS-9
Microinjections
Embryonic Stem Cell Injections
Others

Segmentation 2: By Animal Type

Rodent (Mice & Rats)
Rabbits
Pigs
Others

Segmentation 3: By Application

Drug Discovery and Development
Disease Research
Gene Function Studies
Toxicology and Safety Testing
Others

Segmentation 4: By End User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations (CROs)

Segmentation 5: by Country

Germany
U.K.
France
Italy
Spain
Rest-of-Europe

Market Trends, Drivers, and Challenges

Market Trends

Increasing adoption of CRISPR/Cas9 and gene-editing technologies
Growing focus on personalized medicine and targeted therapies
Expansion of transgenic models for rare and complex diseases
Rising collaborations between academic institutions and biotech firms

Market Drivers

Growing demand for advanced preclinical models in drug discovery
Increasing R&D investments in biotechnology and life sciences
Rising prevalence of chronic and genetic diseases
Strong regulatory frameworks supporting biomedical research

Market Challenges

Ethical concerns regarding animal testing and genetic modification
High cost and complexity of developing transgenic models
Stringent regulatory requirements across European countries
Limitations in replicating certain human disease conditions accurately

How This Report Can Add Value?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in transgenic animal model, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors’ strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines, ensuring organizations stay compliant and accelerate market entry for new transgenic animal model products.

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

genOway
Sigma-Aldrich Co. (Merck Group)
Janvier Group

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 1-5 business days to complete the report upon order confirmation.

Table of Contents

80 Pages
Executive Summary
Scope and Definition
1 Market: Industry Outlook
1.1 Market Overview
1.1.1 Market Overview and Ecosystem
1.2 Market Trends
1.2.1 Impact Analysis
1.2.2 Rising Demand for Personalized Medicine
1.3 Regulatory Landscape
1.3.1 Europe
1.3.1.1 Germany
1.3.1.2 U.K.
1.4 Pricing Analysis
1.4.1 Generation Costs (Creating New Models)
1.4.2 Acquisition Costs (Purchasing Existing Models)
1.4.3 Additional Costs
1.5 Technology Landscape
1.6 Market Dynamics
1.6.1 Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
1.6.2 Market Drivers
1.6.2.1 Growing Number of Pharmaceutical Research and Drug Development Activities
1.6.2.2 Technological Advancements in Genetic Engineering
1.6.2.3 Increasing Demand for Advanced Disease Models for Drug Discovery
1.6.3 Market Restraints
1.6.3.1 High Maintenance Cost of Animal Models
1.6.3.2 Strict Regulations and Guidelines
1.6.4 Market Opportunities
1.6.4.1 Emergence of CRISPR as a Powerful Tool for Biomedical Research Field
1.6.4.2 Increasing Demand for Disease-Specific Models
2 Region
2.1 Regional Summary
2.2 Europe
2.2.1 Regional Overview
2.2.2 Driving Factors for Market Growth
2.2.3 Factors Challenging the Market
2.2.4 Market Sizing and Forecast
2.2.4.1 Europe Transgenic Animal Model Market, by Technology
2.2.4.2 Europe Transgenic Animal Model Market, by Animal Type
2.2.4.3 Europe Transgenic Animal Model Market, by Application
2.2.4.4 Europe Transgenic Animal Model Market, by End User
2.2.4.5 Europe Transgenic Animal Model Market, by Country
2.2.5 U.K.
2.2.5.1 Country Overview
2.2.5.2 U.K. Transgenic Animal Model Market, by Technology
2.2.5.3 U.K. Transgenic Animal Model Market, by Animal Type
2.2.5.4 U.K. Transgenic Animal Model Market, by Application
2.2.5.5 U.K. Transgenic Animal Model Market, by End User
2.2.6 Germany
2.2.6.1 Country Overview
2.2.6.2 Germany Transgenic Animal Model Market, by Technology
2.2.6.3 Germany Transgenic Animal Model Market, by Animal Type
2.2.6.4 Germany Transgenic Animal Model Market, by Application
2.2.6.5 Germany Transgenic Animal Model Market, by End User
2.2.7 France
2.2.7.1 Country Overview
2.2.7.2 France Transgenic Animal Model Market, by Technology
2.2.7.3 France Transgenic Animal Model Market, by Animal Type
2.2.7.4 France Transgenic Animal Model Market, by Application
2.2.7.5 France Transgenic Animal Model Market, by End User
2.2.8 Italy
2.2.8.1 Country Overview
2.2.8.2 Italy Transgenic Animal Model Market, by Technology
2.2.8.3 Italy Transgenic Animal Model Market, by Animal Type
2.2.8.4 Italy Transgenic Animal Model Market, by Application
2.2.8.5 Italy Transgenic Animal Model Market, by End User
2.2.9 Spain
2.2.9.1 Country Overview
2.2.9.2 Spain Transgenic Animal Model Market, by Technology
2.2.9.3 Spain Transgenic Animal Model Market, by Animal Type
2.2.9.4 Spain Transgenic Animal Model Market, by Application
2.2.9.5 Spain Transgenic Animal Model Market, by End User
2.2.10 Rest-of-the- Europe
2.2.10.1 Country Overview
2.2.10.2 Rest of the Europe Transgenic Animal Model Market, by Technology
2.2.10.3 Rest of the Europe Transgenic Animal Model Market, by Animal Type
2.2.10.4 Rest of the Europe Transgenic Animal Model Market, by Application
2.2.10.5 Rest of the Europe Transgenic Animal Model Market, by End User
3 Competitive Benchmarking and Company Profiles
3.1 Company Profiles
3.1.1 genOway
3.1.1.1 Overview
3.1.2 Sigma-Aldrich Co. (Merck Group)
3.1.2.1 Overview
3.1.3 Janvier Group (Janvier Labs)
3.1.3.1 Overview
4 Research Methodology
4.1 Data Sources
4.1.1 Primary Data Sources
4.1.2 Secondary Data Sources
4.1.3 Inclusion and Exclusion
4.1.4 Data Triangulation
4.2 Market Estimation and Forecast
List of Figures
Figure 1: Europe Transgenic Animal Model Market (by Scenario), $Million, 2024, 2028, and 2035
Figure 2: Europe Transgenic Animal Model Market, 2024 and 2035
Figure 3: Europe Transgenic Animal Model Market Snapshot
Figure 4: Transgenic Animal Model Market, $Million, 2024 and 2035
Figure 5: Europe Transgenic Animal Model Market (by Technology), $Million, 2024, 2028, and 2035
Figure 6: Europe Transgenic Animal Model Market (by Animal Type), $Million, 2024, 2028, and 2035
Figure 7: Europe Transgenic Animal Model Market (by Application), $Million, 2024, 2028, and 2035
Figure 8: Europe Transgenic Animal Model Market (by End User), $Million, 2024, 2028, and 2035
Figure 9: Europe Transgenic Animal Model Market Segmentation
Figure 10: Key Stakeholders of Transgenic Animal Model Market
Figure 11: Transgenic Animals: Timeline of Key Events
Figure 12: Role of Humanized Mouse Models in Development of New Precision and Personalized Medicine Strategies
Figure 13: Regulatory Bodies of Transgenic Animals in Europe
Figure 14: Regulatory Bodies of Transgenic Animals in Germany
Figure 15: Regulatory Process
Figure 16: Evolution of Transgenic Technologies
Figure 17: Europe Drug Development Pipeline, 2019 and 2024
Figure 18: Major Technical Advances in Genome Editing and Delivery in Mice and Rats from 1980s to 2020s
Figure 19: Europe Transgenic Animal Model Market, $Million, 2024-2035
Figure 20: Inclusion and Exclusion Criteria for Europe Transgenic Animal Model Market
Figure 21: Data Triangulation
Figure 22: Top-Down and Bottom-Up Approach
Figure 23: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: Cost of Generating New Transgenic Animals
Table 3: Cost of Purchasing Existing Models
Table 4: Additional Costs
Table 5: Transgenic Animal Model Market (by Region), $Million, 2024-2035
Table 6: Europe Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 7: Europe Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 8: Europe Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 9: Europe Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 10: Europe Transgenic Animal Model Market (by Country), $Million, 2024-2035
Table 11: U.K. Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 12: U.K. Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 13: U.K. Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 14: U.K. Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 15: Germany Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 16: Germany Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 17: Germany Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 18: Germany Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 19: France Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 20: France Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 21: France Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 22: France Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 23: Italy Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 24: Italy Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 25: Italy Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 26: Italy Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 27: Spain Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 28: Spain Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 29: Spain Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 30: Spain Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 31: Rest of the Europe Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 32: Rest of the Europe Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 33: Rest of the Europe Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 34: Rest of the Europe Transgenic Animal Model Market (by End User), $Million, 2024-2035

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us